Anti‐glypican‐1 antibody‐drug conjugate exhibits potent preclinical antitumor activity against glypican‐1 positive uterine cervical cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0215|142|5|1056-1066

ISSN： 0020-7136

Source： INTERNATIONAL JOURNAL OF CANCER, Vol.142, Iss.5, 2018-03, pp. : 1056-1066

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunohistochemical Study of Glypican 3 in Thyroid Cancer

By  

Oncology, Vol. 73, Iss. 5-6, 2008-05 ,pp. : 389-394

Karger

Access to resources Recommend Favorite

Quantification of glypican 3, β‐catenin and claudin‐1 protein expression in hepatoblastoma and paediatric hepatocellular carcinoma by colour deconvolution

By  

HISTOPATHOLOGY, Vol. 67, Iss. 6, 2015-12 ,pp. : 905-913

John Wiley & Sons Inc

Access to resources Recommend Favorite

Insulin‐like growth factor‐1 receptor (IGF‐1R) inhibition promotes expansion of human NK cells which maintain their potent antitumor activity against Ewing sarcoma cells

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 11, 2015-11 ,pp. : 1979-1985

John Wiley & Sons Inc

Access to resources Recommend Favorite

Insulin‐like growth factor‐1 receptor (IGF‐1R) inhibition promotes expansion of human NK cells which maintain their potent antitumor activity against Ewing sarcoma cells

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 1545-5009, Iss. 11, 2015-11 ,pp. : 1979-1985

John Wiley & Sons Inc

Access to resources Recommend Favorite

Antitumor activity of an anti‐CD98 antibody

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 3, 2015-08 ,pp. : 710-720

John Wiley & Sons Inc

Access to resources Recommend Favorite